Loading…
Bodyhealth.com, LLC, a company marketing drug products, received an FDA Warning Letter on December 9, 2020. Based on the limited metadata available, the specific nature of the violations cannot be determined as the subject line was not provided. The warning letter was issued under FDA's drug product regulatory authority, though the specific issuing office is not identified in the available records. Without access to the full letter text, the precise compliance issues and required corrective actions remain unclear.